SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-001414
Filing Date
2023-02-16
Accepted
2023-02-16 08:14:06
Documents
20
Period of Report
2023-02-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K adap-20230215x8k.htm   iXBRL 8-K 41990
2 EX-10.1 adap-20230215xex10d1.htm EX-10.1 167359
3 EX-99.1 adap-20230215xex99d1.htm EX-99.1 10637
4 GRAPHIC adap-20230215xex10d1001.jpg GRAPHIC 2489
5 GRAPHIC adap-20230215xex10d1002.jpg GRAPHIC 9125
6 GRAPHIC adap-20230215xex10d1003.jpg GRAPHIC 862
7 GRAPHIC adap-20230215xex10d1006.jpg GRAPHIC 4096
8 GRAPHIC adap-20230215xex10d1007.jpg GRAPHIC 833
9 GRAPHIC adap-20230215xex99d1001.jpg GRAPHIC 10901
  Complete submission text file 0001558370-23-001414.txt   410553

Data Files

Seq Description Document Type Size
10 EX-101.SCH adap-20230215.xsd EX-101.SCH 3369
11 EX-101.LAB adap-20230215_lab.xml EX-101.LAB 15972
12 EX-101.PRE adap-20230215_pre.xml EX-101.PRE 10791
14 EXTRACTED XBRL INSTANCE DOCUMENT adap-20230215x8k_htm.xml XML 4916
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37368 | Film No.: 23637204
SIC: 2836 Biological Products, (No Diagnostic Substances)